The lack of increased CD8+ T-cell activation may relate to the large majority of BT COVID-19 in our study being mild and/or the timing of blood sampling post–BT infection, given that CD8+ T cells are usually only activated for a few weeks. The gene discussed is CD8A; the disease is COVID-19.